跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brevinor-1 28 Day tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
Brevinor-1 28 Day tablet blister pack
Approved
STANDARD
Brevinor-1 28 Day tablet blister pack
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
1281eeef13511240
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1281eeef13511240
Product Name
Brevinor-1 28 Day tablet blister pack
Artg Id
62134
Artg Name
BREVINOR-1 28 DAY tablet blister pack
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1998-01-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a8aa83c8fadc1ab2c137fdd6c76f285a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/775bcb9e358865c3902c73c713108164.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
1281eeef13511240
Type
Standard
Back to TGA Approvals